Getinge 2022 Annual Report
Getinge 2022 Annual Report
Introduction
Strategy
Corporate Governance
Annual Report
Sustainability Report
Other information
Contents
Business area news
•
•
Elin Frostehav was appointed new President Acute Care
Therapies after leading the Critical Care product area for
the past three years
Getinge was awarded a three-year contract for anesthetic
devices by Premier Inc., a healthcare organization in the US
that encompasses 4,400 hospitals and health systems
• A study was published in the Journal of Clinical Monitoring
and Computing that demonstrated that the unique Automatic
Gas Control (AGC) in Getinge's anesthesia machine Flow-i can
help hospitals to reduce their anesthesia emissions by up to
58%. A new system for the anesthesia product family Flow was
launched, which means that AGC will also become available
for the Flow-c and Flow-e product flows
• Production of ventilators in Suzhou, China, commenced.
This was an important step in securing continued contracts
in the Chinese market
•
Getinge won the IF Design Award for GUIDE - a new user
interface that is designed for acute care environments with
more advanced devices and where the need for recognition
and user-friendliness is on the rise
• A supply partnership was entered together with Medtronic,
which received the CE mark for Radiant TM, the first covered stent
indicated for chimney endovascular aneurysm repair (ChEVAR)
Work to ensure that all Getinge products meet the forthcoming
EU MDR requirements (the EU Medical Device Regulation)
continued and a number of important targets were achieved
during the year:
- Critical Care received MDR certification for all life
support products
- Vascular Systems in Merrimack received the first MDR
certification for vascular implants
•
The US Food & Drug Administration (FDA) included the subsidiary
Datascope as an additional facility in the company's existing
Consent Decree with the US Government. This was based on
observations from previous FDA inspections and a warning
letter related to operational compliance of the company's quality
management system and processes
Focus for the coming years
°
•
•
•
Accelerated growth in attractive segments through
supplementary acquisitions and innovation
Launches of advanced products and new digital solutions
that contribute to sustainable healthcare
Intensification of productivity to support margin improvements
Additional remediation activities to improve and comply with
the quality management system
Above: Getinge's anesthesia machines manufactured in Solna
(Sweden).
To right: Deliveries of vascular grafts from the production site in
La Ciotat (France) reached record levels in 2022.
Poston page Crea
18View entire presentation